Resmed posts double-digit revenue and profit growth in Q2 FY26, declares dividend, and outlines plans for innovation. The Resmed CDI (ASX: RMD) share price is in focus after the company reported ...

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, ...

ResMed (RMD) has quietly drifted lower over the past week, but the stock is still up this year, which raises a straightforward question for investors: is this dip an opportunity or a warning? See our ...

ResMed is rated a buy due to strong fundamentals, expanding margins, robust cash flow, and resilience in recessionary environments. RMD's steady topline growth, high profitability, low debt, and ...

Sleep apnea device maker ResMed will expand its American manufacturing operations and open a new facility in Indianapolis in 2027 but says it is not due to pressure from President Donald Trump for ...

ResMed posted a 9% revenue increase and an 11% rise in net income for the September quarter, driven by increased demand for sleep treatment products. The company demonstrated strong growth in various ...

ResMed’s 2030 strategy focuses on empowering 500 million lives by the end of the decade through its digital health products and cloud-based software solutions. The company reported that it has already ...

ResMed Inc. reported its Q4 2025 earnings, revealing a robust financial performance with revenue reaching $1.35 billion, surpassing the forecast of $1.33 billion. Despite this positive financial ...

Fractus, a company specializing in geometry-based antenna technology and IP licensing, has filed a patent infringement suit against respiratory leader ResMed. The complaint was filed in the United ...

ResMed plans to sign a lease for an about 446,500-square-foot building on Collins Road in Greenwood. The company is seeking a nearly $500,000 three-year tax break from the Greenwood City Council.

ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript July 31, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.55, expectations were $2.49. Operator: Hello, and welcome to the Q4 ...

Resmed Inc (NYSE:RMD) reported better-than-expected earnings for the second quarter on Thursday. The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of ...